Retinal vein occlusion occurs when one of the tiny veins in the retina becomes blocked by a blood clot.
What is retinal vein occlusion?
This is a serious condition, which can affect your vision, caused by a blood clot in a tiny vein in the retina (the seeing membrane in your eye). The retina is a thin, light-sensitive membrane that lines the back of your eye.
An occlusion is a medical term for blockage so retinal vein occlusion means the retinal vein is blocked. This stops blood draining away from the retina and blood 'backs up' behind the blockage. Fluid and blood will then leak from the blood vessels into the delicate tissue of the retina, forcing its layers apart and affecting its ability to respond to light.
Who gets retinal vein occlusion and why?
Retinal vein occlusion is a fairly common cause of loss of vision in the UK. It is most common in people over the age of 60 years.
It happens because the vein is blocked. This blockage may occur either because of pressure on the outside of the vein (usually from a retinal artery) which squashes or kinks it, or because of sludging of fatty deposits or clotting of blood inside the vein, forming a plug.
Conditions which increase the risk of retinal vein occlusion include:
- High blood pressure.
- High cholesterol/high lipid levels.
- Raised pressure in the eye (glaucoma).
- Conditions which 'thicken' the blood.
Did you find this information useful?
- Retinal Vein Occlusion (RVO) Guidelines; Royal College of Ophthalmologists (July 2015)
- Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion, NICE Technology Appraisal Guidance, February 2014
- Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion; NICE Technology Appraisal Guidance, September 2016
- Arteriovenous crossing sheathotomy for branch retinal vein occlusion, NICE Interventional Procedure Guidance, March 2010
- Dexamethasone intravitreal implant for the treatment of macular oedema caused by retinal vein occlusion; NICE Technology Appraisal Guidance, July 2011
- Anti-VEGF for Retinal Vein Occlusion: Patient Information; Moorfields Eye Hospital
- Ozurdex® - Patient Information: for patients with macular oedema due to branch retinal vein occlusion or central retinal vein occlusion; Moorfields Eye Hospital
- Patel A, Nguyen C, Lu S; Central Retinal Vein Occlusion: A Review of Current Evidence-based Treatment Options. Middle East Afr J Ophthalmol. 2016 Jan-Mar 23(1):44-8. doi: 10.4103/0974-9233.173132.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. Patient Platform Limited has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.